Fusion Pharmaceuticals Inc. Current Assets
Fusion Pharmaceuticals Inc. had Current Assets of $220.92 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2024-05-07
- 2024-03-31: Assets, Current $220.92M.
- 2023-12-31: Assets, Current $243.40M.
- 2023-09-30: Assets, Current $203.26M.
- 2023-06-30: Assets, Current $207.86M.
| Period end | Assets, Current |
|---|---|
| 2024-03-31 | $220.92M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $243.40M 10-Q · filed 2024-05-07 |
| 2023-09-30 | $203.26M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $207.86M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $220.62M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $179.00M 10-K · filed 2024-03-20 |
| 2022-09-30 | $215.85M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $207.07M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $204.78M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $211.76M 10-K · filed 2023-03-16 |
| 2021-09-30 | $203.01M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $185.16M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $233.85M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $228.16M 10-K · filed 2022-03-17 |
| 2020-09-30 | $296.88M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $320.13M 10-Q · filed 2020-08-11 |
| 2019-12-31 | $66.55M 10-K · filed 2021-03-25 |